Australian study uncovers first potential prophylactic treatment against HTLV-1

Study identifies world-first treatments to prevent a life-threatening virus infection

Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease that currently has no preventative treatments and no cure.

Australian study finds potential treatment for virus impacting millions

A landmark Australian study may have found a treatment and cure for a virus that impacts 10 million people worldwide.Human T-Cell leukaemia type 1 (HTLV-1) is a life-threatening virus that impacts the immune system and the blood cells involved in fighting off infection within the body.Research on HTLV-1 has been sparse, but a study conducted by the Walter and Eliza Hall Institute of Medical Research (WEHI) and the Doherty Institute in Melbourne …

Australian study uncovers first potential prophylactic treatment against HTLV-1

Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease that currently has no preventative treatments and no cure.

First treatments to prevent life-threatening virus infection identifie

Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease that currently has no preventative treatments and no cure. But a landmark study co-led by WEHI and the Peter Doherty Institute for Infection and Immunity (Doherty Institute) could change this, after finding existing HIV drugs can suppress transmission of the HTLV-1 virus in mice.